Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
US Stock MarketDetailed Quotes
MYNZ Mainz Biomed
- 2.980
- -0.350-10.51%
Close Apr 4 16:00 ET
- 2.800
- -0.180-6.04%
Post 19:57 ET
9.06MMarket Cap-0.13P/E (TTM)
3.130High2.650Low92.04KVolume3.130Open3.330Pre Close269.94KTurnover3.38%Turnover RatioLossP/E (Static)3.04MShares45.20052wk High1.50P/B8.11MFloat Cap2.65052wk Low--Dividend TTM2.72MShs Float1200.000Historical High--Div YieldTTM14.41%Amplitude2.650Historical Low2.932Avg Price1Lot Size
Mainz Biomed News
Mainz Biomed | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mainz Biomed | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mainz Biomed | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mainz Biomed | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mainz Biomed | F-1/A: Registration statement for securities of certain Canadian issuers (Amendment)
Mainz Biomed | F-1/A: Registration statement for securities of certain Canadian issuers (Amendment)
Mainz Biomed | F-1/A: Registration statement for securities of certain Canadian issuers (Amendment)
Mainz Biomed | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mainz Biomed | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mainz Biomed | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mainz Biomed | F-1: Registration statement for securities of certain foreign private issuers
Mainz Biomed | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mainz Biomed | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mainz Biomed | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mainz Biomed | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mainz Biomed | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mainz Biomed | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mainz Biomed | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mainz Biomed | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mainz Biomed | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call